Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

The complexity of tumor histomorphology reflects underlying tumor biology impacting on natural course and response to treatment. This study presents a method of computer-aided analysis of tissue sections, relying on multifractal (MF) analyses, of cytokeratin-stained tumor sections which quantitatively evaluates of the morphological complexity of the tumor-stroma interface. This approach was applied to colon cancer collection, from an adjuvant treatment randomized study. Metrics obtained with the method acted as independent markers for natural course of the disease, and for benefit of adjuvant treatment. Comparative analyses demonstrated that MF metrics out-performed standard histomorphological features such as tumor grade, budding and configuration of invasive front. Notably, the MF analyses-derived “αmax” –metric constitutes the first response-predictive biomarker in stage II-III colon cancer showing significant interactions with treatment in analyses using a randomized trial-derived study population. Based on these results the method appears as an attractive and easy-to-implement tool for biomarker identification.

[1]  R. Salazar,et al.  Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Patsouris,et al.  Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer , 2013, Modern Pathology.

[3]  Misha Eliasziw,et al.  Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival , 2010, Journal of Translational Medicine.

[4]  Andrew H. Beck,et al.  Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.

[5]  H. Grönberg,et al.  Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. , 2003, Acta oncologica.

[6]  M. Somerfield,et al.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Meyerhardt,et al.  Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer , 2012, Annals of Surgical Oncology.

[8]  H. Blomgren,et al.  Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Chunxiang Qian,et al.  Comparing Monofractal and Multifractal Analysis of Corrosion Damage Evolution in Reinforcing Bars , 2012, PloS one.

[10]  T. Hansen,et al.  Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature , 2015, Acta oncologica.

[11]  Wolfgang Weidner,et al.  On the relationship between tumor structure and complexity of the spatial distribution of cancer cell nuclei: A fractal geometrical model of prostate carcinoma , 2015, The Prostate.

[12]  Viktor H. Koelzer,et al.  The Tumor Border Configuration of Colorectal Cancer as a Histomorphological Prognostic Indicator , 2014, Front. Oncol..

[13]  R. Labianca,et al.  Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Påhlman,et al.  Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated? , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Compton,et al.  Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Gianguido C. Cianci,et al.  Lung cancer—a fractal viewpoint , 2015, Nature Reviews Clinical Oncology.

[17]  L. Bodin,et al.  Characterization of colon carcinoma growth pattern by computerized morphometry: definition of a complexity index. , 2008, International journal of molecular medicine.

[18]  R W Wilkinson,et al.  Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype , 2013, British Journal of Cancer.

[19]  K. Kanjer,et al.  Multifractal analysis of tumour microscopic images in the prediction of breast cancer chemotherapy response , 2015, Biomedical Microdevices.

[20]  Daniela Ciobanu,et al.  A pilot study on the role of fractal analysis in the microscopic evaluation of colorectal cancers. , 2015, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[21]  R J Salmon,et al.  [Prognostic factors of colorectal cancer]. , 1989, Pathologie-biologie.

[22]  M E Hammond,et al.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[23]  Zu-Guo Yu,et al.  Multifractal analysis of solar flare indices and their horizontal visibility graphs , 2012 .

[24]  Inti Zlobec,et al.  Tumor budding in colorectal cancer--ready for diagnostic practice? , 2016, Human pathology.

[25]  K. Öhrling,et al.  A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer. , 2013, Clinical colorectal cancer.

[26]  Zu-Guo Yu,et al.  Determination of multifractal dimensions of complex networks by means of the sandbox algorithm. , 2014, Chaos.

[27]  I. Zlobec,et al.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. , 2009, World journal of gastroenterology.

[28]  Konradin Metze,et al.  Fractal dimension of chromatin: potential molecular diagnostic applications for cancer prognosis , 2013, Expert review of molecular diagnostics.

[29]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[30]  R. Labianca,et al.  ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  C. Ratto,et al.  Prognostic factors in colorectal cancer , 1998, Diseases of the colon and rectum.